Novel recombinant adenovirus vector with relieved side effects
The present invention provides a novel adenovirus vector for which inflammation during the in vivo administration thereof is alleviated by inhibiting the induction of expression of an adenovirus gene by a foreign promoter inserted into the adenovirus genome, and a method for producing the vector, a...
Saved in:
Main Author | |
---|---|
Format | Patent |
Language | English |
Published |
03.01.2007
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention provides a novel adenovirus vector for which inflammation during the in vivo administration thereof is alleviated by inhibiting the induction of expression of an adenovirus gene by a foreign promoter inserted into the adenovirus genome, and a method for producing the vector, a cell line for use in the production of said recombinant adenovirus vector, or a gene therapy method using said recombinant adenovirus vector. |
---|---|
Bibliography: | Application Number: CN20018011685 |